Effect of panchakarma therapies on amavata

Effect of virechana andd basti karma on serum levels of complement proteins in patients with amavata wsr to rheumatoid arthritis a randomised exploratory controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100143

Enrollment

Registered

2026-01-01

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling the diagnostic criteria Patient fit for Virechana and basti Patient undergoing virechana Patient undergoing basti Patient who is not on any anti rheumatic drug from last 30 days.

Exclusion criteria

Exclusion criteria: K/C/O of Diabetes Mellitus, Irritable bowel Syndrome. Pregnant and lactating women. Patients on any anti-lipidemic drugs.

Design outcomes

Primary

Measure	Time frame
Changes in C3 and C4 complement protein and TNF AlphaTimepoint: 0th day and 30th day	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactDr Vishwanath S Wasedar

KAHERs Shri B M kankanwadi Mahavidyalaya

svishwa_w@yahoo.co.in8494946898

Outcome results